(G) Genpact - Ratings and Ratios
Outsourcing, Analytics, Consulting, Automation, Finance
G EPS (Earnings per Share)
G Revenue
Description: G Genpact November 03, 2025
Genpact Limited (NYSE:G) is a global provider of business-process outsourcing (BPO) and information-technology services, operating across North America, Latin America, Europe, India and the rest of Asia. The firm is organized into three verticals-Financial Services; Consumer & Healthcare; and High-Tech & Manufacturing-each delivering end-to-end solutions ranging from loan processing and compliance in finance to revenue-cycle management in health care and supply-chain engineering for manufacturers.
Based on FY 2023 results (the latest publicly disclosed figures), Genpact generated roughly **$4.0 billion** in revenue, with an **operating margin of ~12%** and a **year-over-year revenue growth of 12%** driven largely by digital-transformation contracts. The company’s **backlog**-the value of signed but un-delivered work-stood at about **$8 billion**, indicating a multi-year revenue runway. Client concentration remains modest, with the top 10 customers contributing less than **10%** of total revenue, which mitigates single-client risk.
Key macro-economic drivers for Genpact include the accelerating **outsourcing spend in regulated sectors** (especially financial services) as firms seek to meet expanding compliance burdens, and the broader **adoption of AI-enabled automation** that fuels demand for data-tech and CFO advisory services. Additionally, near-shoring trends in North America are prompting enterprises to shift non-core functions to specialized providers like Genpact, supporting a secular growth tail.
For a deeper, data-driven valuation framework, you might explore the detailed metrics on ValueRay.
G Stock Overview
| Market Cap in USD | 6,648m |
| Sub-Industry | Data Processing & Outsourced Services |
| IPO / Inception | 2007-08-02 |
G Stock Ratings
| Growth Rating | -13.6% |
| Fundamental | 82.6% |
| Dividend Rating | 56.5% |
| Return 12m vs S&P 500 | -5.30% |
| Analyst Rating | 3.91 of 5 |
G Dividends
| Dividend Yield 12m | 1.87% |
| Yield on Cost 5y | 2.22% |
| Annual Growth 5y | 11.78% |
| Payout Consistency | 56.9% |
| Payout Ratio | 25.2% |
G Growth Ratios
| Growth Correlation 3m | -85.8% |
| Growth Correlation 12m | -50% |
| Growth Correlation 5y | -14.1% |
| CAGR 5y | 0.90% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.03 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.05 |
| Sharpe Ratio 12m | -0.55 |
| Alpha | -0.84 |
| Beta | 0.895 |
| Volatility | 25.43% |
| Current Volume | 7042.7k |
| Average Volume 20d | 1682.3k |
| Stop Loss | 43.1 (-3.1%) |
| Signal | 0.61 |
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income (538.3m TTM) > 0 and > 6% of Revenue (6% = 295.7m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 1.74pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.07% (prev 23.28%; Δ -8.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 649.5m > Net Income 538.3m (YES >=105%, WARN >=100%) |
| Net Debt (868.3m) to EBITDA (880.0m) ratio: 0.99 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.53 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (177.1m) change vs 12m ago -2.13% (target <= -2.0% for YES) |
| Gross Margin 35.63% (prev 35.37%; Δ 0.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 94.01% (prev 88.63%; Δ 5.38pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.98 (EBITDA TTM 880.0m / Interest Expense TTM 79.1m) >= 6 (WARN >= 3) |
Altman Z'' 3.00
| (A) 0.14 = (Total Current Assets 2.14b - Total Current Liabilities 1.39b) / Total Assets 5.31b |
| (B) 0.25 = Retained Earnings (Balance) 1.35b / Total Assets 5.31b |
| (C) 0.15 = EBIT TTM 789.0m / Avg Total Assets 5.24b |
| (D) 0.23 = Book Value of Equity 621.6m / Total Liabilities 2.72b |
| Total Rating: 3.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.59
| 1. Piotroski 9.50pt = 4.50 |
| 2. FCF Yield 7.50% = 3.75 |
| 3. FCF Margin 11.43% = 2.86 |
| 4. Debt/Equity 0.59 = 2.33 |
| 5. Debt/Ebitda 0.99 = 1.79 |
| 6. ROIC - WACC (= 7.88)% = 9.85 |
| 7. RoE 21.92% = 1.83 |
| 8. Rev. Trend 93.33% = 7.00 |
| 9. EPS Trend -26.08% = -1.30 |
What is the price of G shares?
Over the past week, the price has changed by +16.62%, over one month by +9.31%, over three months by +7.06% and over the past year by +7.98%.
Is Genpact a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of G is around 40.66 USD . This means that G is currently overvalued and has a potential downside of -8.61%.
Is G a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the G price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.3 | 13.1% |
| Analysts Target Price | 50.3 | 13.1% |
| ValueRay Target Price | 45 | 1.2% |
G Fundamental Data Overview November 04, 2025
P/E Trailing = 12.6744
P/E Forward = 18.315
P/S = 1.3488
P/B = 2.7893
P/EG = 1.7
Beta = 0.895
Revenue TTM = 4.93b USD
EBIT TTM = 789.0m USD
EBITDA TTM = 880.0m USD
Long Term Debt = 833.4m USD (from longTermDebt, last quarter)
Short Term Debt = 525.0m USD (from shortTermDebt, last quarter)
Debt = 1.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 868.3m USD (from netDebt column, last quarter)
Enterprise Value = 7.52b USD (6.65b + Debt 1.53b - CCE 663.3m)
Interest Coverage Ratio = 9.98 (Ebit TTM 789.0m / Interest Expense TTM 79.1m)
FCF Yield = 7.50% (FCF TTM 563.4m / Enterprise Value 7.52b)
FCF Margin = 11.43% (FCF TTM 563.4m / Revenue TTM 4.93b)
Net Margin = 10.92% (Net Income TTM 538.3m / Revenue TTM 4.93b)
Gross Margin = 35.63% ((Revenue TTM 4.93b - Cost of Revenue TTM 3.17b) / Revenue TTM)
Gross Margin QoQ = 35.88% (prev 35.31%)
Tobins Q-Ratio = 1.42 (Enterprise Value 7.52b / Total Assets 5.31b)
Interest Expense / Debt = 1.18% (Interest Expense 18.0m / Debt 1.53b)
Taxrate = 24.91% (44.0m / 176.7m)
NOPAT = 592.5m (EBIT 789.0m * (1 - 24.91%))
Current Ratio = 1.53 (Total Current Assets 2.14b / Total Current Liabilities 1.39b)
Debt / Equity = 0.59 (Debt 1.53b / totalStockholderEquity, last quarter 2.59b)
Debt / EBITDA = 0.99 (Net Debt 868.3m / EBITDA 880.0m)
Debt / FCF = 1.54 (Net Debt 868.3m / FCF TTM 563.4m)
Total Stockholder Equity = 2.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.14% (Net Income 538.3m / Total Assets 5.31b)
RoE = 21.92% (Net Income TTM 538.3m / Total Stockholder Equity 2.46b)
RoCE = 23.99% (EBIT 789.0m / Capital Employed (Equity 2.46b + L.T.Debt 833.4m))
RoIC = 15.61% (NOPAT 592.5m / Invested Capital 3.80b)
WACC = 7.73% (E(6.65b)/V(8.18b) * Re(9.31%) + D(1.53b)/V(8.18b) * Rd(1.18%) * (1-Tc(0.25)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.73%
[DCF Debug] Terminal Value 75.24% ; FCFE base≈521.9m ; Y1≈571.0m ; Y5≈725.2m
Fair Price DCF = 57.84 (DCF Value 10.08b / Shares Outstanding 174.3m; 5y FCF grow 10.74% → 3.0% )
EPS Correlation: -26.08 | EPS CAGR: -57.32% | SUE: -4.0 | # QB: 0
Revenue Correlation: 93.33 | Revenue CAGR: 4.51% | SUE: 0.99 | # QB: 1
Additional Sources for G Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle